These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 25504613)

  • 1. Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.
    Sajic T; Liu Y; Aebersold R
    Proteomics Clin Appl; 2015 Apr; 9(3-4):307-21. PubMed ID: 25504613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS.
    Liu Y; Hüttenhain R; Surinova S; Gillet LC; Mouritsen J; Brunner R; Navarro P; Aebersold R
    Proteomics; 2013 Apr; 13(8):1247-56. PubMed ID: 23322582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in targeted proteomics for clinical applications.
    Domon B; Gallien S
    Proteomics Clin Appl; 2015 Apr; 9(3-4):423-31. PubMed ID: 25504492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Acquisition and Data-Processing Parameters for Improved Proteomic Quantification by Sequential Window Acquisition of All Theoretical Fragment Ion Mass Spectrometry.
    Li S; Cao Q; Xiao W; Guo Y; Yang Y; Duan X; Shui W
    J Proteome Res; 2017 Feb; 16(2):738-747. PubMed ID: 27995803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric protein maps for biomarker discovery and clinical research.
    Liu Y; Hüttenhain R; Collins B; Aebersold R
    Expert Rev Mol Diagn; 2013 Nov; 13(8):811-25. PubMed ID: 24138574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry-based proteomic quest for diabetes biomarkers.
    Shao S; Guo T; Aebersold R
    Biochim Biophys Acta; 2015 Jun; 1854(6):519-27. PubMed ID: 25556002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition.
    Vidova V; Spacil Z
    Anal Chim Acta; 2017 Apr; 964():7-23. PubMed ID: 28351641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring.
    Law KP; Lim YP
    Expert Rev Proteomics; 2013 Dec; 10(6):551-66. PubMed ID: 24206228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted proteomics: a bridge between discovery and validation.
    Harlan R; Zhang H
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWATH Mass Spectrometry for Proteomics of Non-Depleted Plasma.
    Krisp C; Molloy MP
    Methods Mol Biol; 2017; 1619():373-383. PubMed ID: 28674897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated SWATH Data Analysis Using Targeted Extraction of Ion Chromatograms.
    Röst HL; Aebersold R; Schubert OT
    Methods Mol Biol; 2017; 1550():289-307. PubMed ID: 28188537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S; Kislinger T
    Mol Biosyst; 2011 Feb; 7(2):292-303. PubMed ID: 20976349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques.
    Meyer JG; Schilling B
    Expert Rev Proteomics; 2017 May; 14(5):419-429. PubMed ID: 28436239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma.
    Luo Y; Mok TS; Lin X; Zhang W; Cui Y; Guo J; Chen X; Zhang T; Wang T
    Sci Rep; 2017 Jan; 7():41191. PubMed ID: 28117408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplexed and data-independent tandem mass spectrometry for global proteome profiling.
    Chapman JD; Goodlett DR; Masselon CD
    Mass Spectrom Rev; 2014; 33(6):452-70. PubMed ID: 24281846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A repository of assays to quantify 10,000 human proteins by SWATH-MS.
    Rosenberger G; Koh CC; Guo T; Röst HL; Kouvonen P; Collins BC; Heusel M; Liu Y; Caron E; Vichalkovski A; Faini M; Schubert OT; Faridi P; Ebhardt HA; Matondo M; Lam H; Bader SL; Campbell DS; Deutsch EW; Moritz RL; Tate S; Aebersold R
    Sci Data; 2014; 1():140031. PubMed ID: 25977788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SWATH-MS as a tool for biomarker discovery: From basic research to clinical applications.
    Anjo SI; Santa C; Manadas B
    Proteomics; 2017 Feb; 17(3-4):. PubMed ID: 28127880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in targeted proteomics and applications to biomedical research.
    Shi T; Song E; Nie S; Rodland KD; Liu T; Qian WJ; Smith RD
    Proteomics; 2016 Aug; 16(15-16):2160-82. PubMed ID: 27302376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.